Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer’s Disease

Serrano-Pozo, Alberto, Mielke, Matthew L., Gómez-Isla, Teresa, Betensky, Rebecca A., Growdon, John H., Frosch, Matthew P., Hyman, Bradley T.·2011·The American Journal of Pathology

Cited by (487)

Items 201–300 of 487

  1. Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid
    Gustaf Boström, Eva Freyhult, Johan Virhammar, Daniel Andres Alcolea, Hayrettin Tumani, Markus Otto, RoseMarie Brundin, Lena Kilander, Malin Löwenmark, Vilmantas Giedraitis et al. · 2021 · Journal of Alzheimer s Disease
  2. Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy
    Chelsey Jenna LeBlang, Maria Medalla, Nicholas William Nicoletti, Emma Catherine Hays, James Zhao, Jenifer E. Shattuck, Anna Lourdes Cruz, Benjamin L. Wolozin, Jennifer Irene Luebke · 2020 · Frontiers in Neuroscience
  3. Therapeutic Potential of Astrocyte Transplantation
    Nataly Hastings, Wei‐Li Kuan, Andrew Osborne, Mark Kotter · 2022 · Cell Transplantation
  4. Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
    Sonia Mazzitelli, Fabia Filipello, Marco Rasile, Eliana Lauranzano, Chiara Starvaggi Cucuzza, Matteo Tamborini, Davide Pozzi, Isabella Barajon, Toni Giorgino A, Antonino Natalello et al. · 2016 · Acta Neuropathologica Communications
  5. Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia
    William Charles Kreisl, Ioline D. Henter, Robert B. Innis · 2017 · Advances in pharmacology
  6. Astrocyte activation and altered metabolism in normal aging, age-related CNS diseases, and HAND
    Bianca Cotto, Kalimuthusamy Natarajaseenivasan, Dianne Langford · 2019 · Journal of NeuroVirology
  7. Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease
    Monika Jürgenson, Tamara Zharkovskaja, Aveli Noortoots, Morozova Ma, Бениашвили Аллан Герович, Max Zapolski, Alexander Zharkovsky · 2019 · Journal of Pharmacy and Pharmacology
  8. PET Agents in Dementia: An Overview
    Aren van Waarde, Sofia Marcolini, Peter Paul De Deyn, Rudi Dierckx · 2021 · Seminars in Nuclear Medicine
  9. The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease
    Khaled S. Abd‐Elrahman, Shaarika Sarasija, Stephen S. G. Ferguson · 2021 · Current Neuropharmacology
  10. Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer’s Disease
    Débora A. Moreira, Sofia Duque Santos, Victoria Leiro, Ana Paula Pêgo · 2023 · Pharmaceutics
  11. The neurobiology of Alzheimer disease defined by neuroimaging
    Joseph C. Masdeu, William Charles Kreisl, Karen Faith Berman · 2012 · Current Opinion in Neurology
  12. The chaperone Clusterin in neurodegeneration−friend or foe?
    Patricia Yuste‐Checa, Andreas Bracher, F. Ulrich Hartl · 2022 · BioEssays
  13. Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease
    J. P. Ferrari-Souza, G. Povala, N. Rahmouni, B. Bellaver, P. Ferreira, M. D. de Bastiani, D. Leffa, F. Lussier, C. Aguzzoli, W. Brum et al. · 2025 · Nature Neuroscience
  14. Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging
    Brandon Coder, Weikan Wang, Liefeng Wang, Zhongdao Wu, Qichuan Zhuge, Dong‐Ming Su · 2016 · Oncotarget
  15. Differential alteration of hippocampal function and plasticity in females and males of the APPxPS1 mouse model of Alzheimer's disease
    Kevin Richetin, Petnoï Petsophonsakul, Laurent Roybon, Bruno Pierre Guiard, Claire Rampon · 2017 · Neurobiology of Aging
  16. Dysfunctional microglia and tau pathology in Alzheimer’s disease
    Gunel Ayyubova · 2022 · Reviews in the Neurosciences
  17. Astrocytic changes with aging and Alzheimer's disease‐type pathology in chimpanzees
    Emily L. Munger, Melissa K. Edler, William Donald Hopkins, John J. Ely, JOSEPH M. ERWIN, Daniel P. Perl, Elliott Jay Mufson, Patrick R. Hof, Chet C. Sherwood, Mary Ann Raghanti · 2018 · The Journal of Comparative Neurology
  18. Astrocyte subtype-specific approach to Alzheimer's disease treatment
    Sukanya Sarkar, Subhas Chandra Biswas · 2021 · Neurochemistry International
  19. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer’s Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss
    Ena Španić, Lea Langer Horvat, Katarina Ilić, Patrick R. Hof, Goran Šimić · 2022 · Cells
  20. The Time Course of Recognition Memory Impairment and Glial Pathology in the hAPP-J20 Mouse Model of Alzheimer’s Disease
    Kamar E. Ameen‐Ali, Julie E. Simpson, Stephen B. Wharton, Paul Roy Heath, Paul S. Sharp, Gaia Brezzo, Jason Berwick · 2019 · Journal of Alzheimer s Disease
  21. Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease
    Kosei Hirata, Kiwamu Matsuoka, Kenji Tagai, Hironobu Endo, Harutsugu Tatebe, Maiko Ono, Naomi Kokubo, Asaka Oyama, Hitoshi Shinotoh, Keisuke Takahata et al. · 2023 · Annals of Neurology
  22. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
    Carolyn Tallon, Benjamin J. Bell, Medhinee M. Malvankar, Pragney Deme, Carlos J. Nogueras‐Ortiz, Erden Eren, Ajit G. Thomas, Kristen R. Hollinger, Arindom Pal, Maja Mustapić et al. · 2023 · Translational Neurodegeneration
  23. Age dependency of mGluR5 availability in 5xFAD mice measured by PET
    Minkyung Lee, Hae‐June Lee, Ye Ji Jeong, Se Jong Oh, Kyung Jun Kang, Sang Jin Han, Kyung Rok Nam, Yong Jin Lee, Kyo Chul Lee, Young Hoon Ryu et al. · 2019 · Neurobiology of Aging
  24. Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease
    Tamàs Fülöp, Usma Munawara, Anis Larbi, Mathieu Desroches, Serafim Rodrigues, Michele Catanzaro, Andrea Guidolin, Abdelouahed Khalil, François Bernier, Annelise E. Barron et al. · 2020 · CNS Drugs
  25. A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases
    Igor Camargo Fontana, Débora Guerini de Souza, Diogo Onofre Souza, Antony D. Gee, Eduardo Rigon Zimmer, Salvatore Bongarzone · 2023 · Journal of Medicinal Chemistry
  26. Central Adiposity and Cortical Thickness in Midlife
    Sonya Kaur, Mitzi M. Gonzales, Barbara Strasser, Evan P. Pasha, Jasmine McNeely, Hirofumi Tanaka, Andreana P. Haley · 2015 · Psychosomatic Medicine
  27. Cross‐sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease
    Madeline Ally, Michael A. Sugarman, Henrik Zetterberg, Kaj Blennow, Nicholas James Ashton, Thomas K. Karikari, Hugo Javier Aparicio, Brandon E. Frank, Yorghos Tripodis, Brett M. Martin et al. · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  28. White Matter Hyperintensities are Positively Associated with Cortical Thickness in Alzheimer's Disease
    Heidi I.L. Jacobs, Lies Clerx, E. H. B. M. Gronenschild, Pauline Aalten, Frans R.J. Verhey · 2014 · Journal of Alzheimer s Disease
  29. Astroglial cell subtypes in the cerebella of normal adults, elderly adults, and patients with <scp>A</scp>lzheimer's disease: A histological and immunohistochemical comparison
    Álvarez, María‐Isabel, Rivas, Luís, Lacruz, César, Toledano, Adolfo · 2015 · Glia
  30. The microglial translocator protein (TSPO) in Alzheimer’s disease reflects a phagocytic phenotype
    Emma F Garland, Henrike Antony, Laura Kulagowska, Thomas Scott, Charlotte Rogien, Michel Bottlaender, James A. R. Nicoll, Delphine Boche · 2024 · Acta Neuropathologica
  31. Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms
    Albert Garcia‐Romeu, Sean Darcy, Hillary Jackson, Toni White, Paul B. Rosenberg · 2021 · Current topics in behavioral neurosciences
  32. Phosphorylation and Dephosphorylation of Tau Protein During Synthetic Torpor
    Marco Luppi, Timna Hitrec, Alessia Di Cristoforo, Fabio Squarcio, Agnese Stanzani, Alessandra Occhinegro, Pierfrancesco Chiavetta, Domenico Tupone, Giovanni Zamboni, Roberto Amici et al. · 2019 · Frontiers in Neuroanatomy
  33. Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: Present and future applications
    Marcella Reale, Isabella Gonzales-Portillo, Cesar V. Borlongan · 2019 · Brain Research
  34. Alzheimer’s Disease, Astrocytes and Kynurenines
    Lívia Dézsi, Bernadett Tuka, Diána Martos, László Vécsei · 2015 · Current Alzheimer Research
  35. Innate immunity in Alzheimer’s disease: the relevance of animal models?
    Diana Franco-Bocanegra, James A. R. Nicoll, Delphine Boche · 2017 · Journal of Neural Transmission
  36. Early microglial and astrocyte reactivity in preclinical Alzheimer's disease
    Marta Fernández‐Matarrubia, Andrea Valera Barrero, Mónica Renuncio‐García, Marcos Aguilella, Carmen Lage, Sara López‐García, Javier Gonzalo Ocejo-Vinyals, Francisco Martínez‐Dubarbie, Guglielmo Di Molfetta, Ana Pozueta‐Cantudo et al. · 2025 · Alzheimer s & Dementia
  37. Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
    Andrea González, Sandeep Kumar Singh, Macarena Churruca, Ricardo Benjamin Maccioni · 2022 · International Journal of Molecular Sciences
  38. Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Grey and White Matter of Brains with Alzheimer’s Disease
    C. Kathleen Dorey, Dennis L. Gierhart, Karlotta A. Fitch, Ian Crandell, Neal E. Craft · 2022 · Journal of Alzheimer s Disease
  39. Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer's Disease Continuum
    Andrei Bieger, A. Rocha, B Bellaver, Luiza Santos Machado, Lucas Uglione Da Ros, Wyllians Vendramini Borelli, Joseph Therriault, Arthur C. Macedo, Tharick Ali Pascoal, Serge G. Gauthier et al. · 2023 · The Journal of Prevention of Alzheimer s Disease
  40. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F]THK5351 uptake in progressive supranuclear palsy
    Kok Pin Ng, Joseph Therriault, Min Su Kang, Hanne Struyfs, Tharick Ali Pascoal, Sulantha Sanjeewa Mathotaarachchi, Monica Shin, Andréa Lessa Benedet, Gassan Massarweh, Jean‐Paul Soucy et al. · 2019 · NeuroImage Clinical
  41. Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity
    Xi Chen, Zhaojin Li, Yong Cheng, Elissavet Kardami, Y. Peng Loh · 2020 · Frontiers in Molecular Neuroscience
  42. Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer’s disease
    Xian Zhou, Madhuri Venigalla, Ritesh Raju, Gerald W Münch · 2022 · Journal of Neural Transmission
  43. Genetic targeting of astrocytes to combat neurodegenerative disease
    GregoryW Kirschen, Rachel Kéry, AllenP. F. Chen · 2019 · Neural Regeneration Research
  44. Upregulation of Alzheimer’s Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo
    Yingxia Liang, Frank Raven, Joseph F. Ward, Sherri Y. Zhen, Siyi Zhang, Haoqi Sun, Sean Miller, Se Hoon Choi, Rudolph E. Tanzi, Can Martin Zhang · 2020 · Journal of Alzheimer s Disease
  45. Association of Odor Identification Ability With Amyloid-β and Tau Burden: A Systematic Review and Meta-Analysis
    Lihui Tu, Xiaozhen Lv, Zili Fan, Ming Zhang, Huali Wang, Xin Yu · 2020 · Frontiers in Neuroscience
  46. Ginsenoside Rg1 attenuates tau phosphorylation in SK-N-SH induced by Aβ‐stimulated THP-1 supernatant and the involvement of p38 pathway activation
    Wei Li, Yanqi Chu, Lan Zhang, Linlin Yin, Lin Li · 2012 · Life Sciences
  47. Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
    Jeswinder Sian‐Hülsmann, Peter Franz Riederer · 2024 · Journal of Neural Transmission
  48. CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease
    Jeremy L. Koppel, Valérie Vingtdeux, Philippe Marambaud, Cristina d’Abramo, Heidy T. Jimenez, Mark Stauber, Rachel Friedman, Peter Davies · 2013 · Molecular Medicine
  49. Continuous Theta-Burst Stimulation Promotes Paravascular CSF-Interstitial Fluid Exchange through Regulation of Aquaporin-4 Polarization in APP/PS1 Mice
    Cheng Wu, Tuo Lin, Qian Ding, Ni Zhang, Zi-tong Ou, Guiyuan Cai, Hongying Chen, Jia-yue Xu, Ge Li, Zhong Pei et al. · 2022 · Mediators of Inflammation
  50. Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities
    Elena Myasoedova, Sebastian Eduardo Sattui, Jihae Lee, John Tiernan O'Brien, Una E. Makris · 2024 · The Lancet Rheumatology
  51. How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells
    Philipp Schaible, Julia Henschel, Daniel Erny · 2025 · Journal of Neuroinflammation
  52. Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice
    Paula de Oliveira, Claire V. Cella, Nicolas Locker, Kiran K G Ravindran, Agampodi Mendis, Keith A. Wafford, Gary Gilmour, Derk‐Jan Dijk, Raphaëlle Winsky‐Sommerer · 2022 · Journal of Neuroscience
  53. Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Microglia from APOE Targeted Replacement Mice
    Isha Mhatre‐Winters, Aseel Eid, Yoonhee Han, Kim Tieu, Jason R. Richardson · 2022 · International Journal of Molecular Sciences
  54. A Systematic Review of the Effects of Capsaicin on Alzheimer’s Disease
    Deborah Inyang, Tasneem Saumtally, Chinelo Nonyerem Nnadi, Sharmila Devi, Po‐Wah So · 2023 · International Journal of Molecular Sciences
  55. Discerning the relationship between microglial activation and Alzheimer’s disease
    William Charles Kreisl · 2017 · Brain
  56. Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration
    BELKOZHAYEV AYAZ MARATOVICH, Minnatallah Al-Yozbaki, Alex George, R. Ye. Niyazova, Kamalidin O. Sharipov, Lee J. Byrne, Cornelia M. Wilson · 2021 · Current Neuropharmacology
  57. Human antimicrobial peptide LL-37 contributes to Alzheimer’s disease progression
    Xue Chen, Suixin Deng, Wenchao Wang, Stefania Castiglione, Zilei Duan, Lei Luo, Francesca Cianci, Xiaoxue Zhang, Jianglei Xu, Hao Li et al. · 2022 · Molecular Psychiatry
  58. Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
    Rolf Antonie Loch, Hongzhi Wang, Alex Perálvarez‐Marín, Philipp Berger, Henrietta M. Nielsen, Angeliki Chroni, Jinghui Luo · 2023 · Computational and Structural Biotechnology Journal
  59. Uncovering Plaque-Glia Niches in Human Alzheimer’s Disease Brains Using Spatial Transcriptomics
    Avey, Denis R., Ng, Bernard, Vialle, Ricardo A., Kearns, Nicola A., de Paiva Lopes, Katia, Iatrou, Artemis, De Tissera, Sashini, Vyas, Himanshu, Saunders, Devin M., Flood, Daniel J. et al. · 2024
  60. Uncovering plaque-glia niches in human Alzheimer’s disease brains using spatial transcriptomics
    Denis R. Avey, Bernard Ng, Ricardo A. Vialle, Nicola A. Kearns, Kátia de Paiva Lopes, Artemis Iatrou, Sashini L De Tissera, Himanshu Vyas, Devin M. Saunders, Daniel J. Flood et al. · 2025 · Molecular Neurodegeneration Advances
  61. Animal Models of Alzheimer’s Disease
    Morgan Newman, Doris Kretzschmar, Imran Khan, Mengqi Chen, Giuseppe Verdile, Michael T. Lardelli · 2017 · Elsevier eBooks
  62. Does Anticholinergic Activity Affect Neuropathology Implication of Neuroinflammation in Alzheimer's Disease
    Yasumasa Yoshiyama, Ayako Kojima, Kimiko Itoh, Sagiri Isose, Mizuho Koide, Koji Hori, Kimihito Arai · 2015 · Neurodegenerative Diseases
  63. Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
    Jared Phillips, Rebecca L. Winfree, Mabel Seto, Julie A. Schneider, David A. Bennett, Logan C. Dumitrescu, Timothy J. Hohman · 2024 · Acta Neuropathologica
  64. Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy
    Yun Chen, Yizhou A. Liu, Khai M. Nguyen, Junjie Wu, Sihui Song, Kent Lin, Patrick Fernandes Rodrigues, Siling Du, Charles Zhou, Kyle Xiong et al. · 2026 · Science
  65. Common Factors of Alzheimer’s Disease and Rheumatoid Arthritis—Pathomechanism and Treatment
    Paulina Trzeciak, Mariola Herbet, Jarosław Dudka · 2021 · Molecules
  66. Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages
    Raquel N. Taddei, Maria Virtudes Sanchez-Mico, Orla Bonnar, Theresa R. Connors, Angelica Gaona, Dominique Denbow, Matthew P. Frosch, Teresa Gómez‐Isla · 2022 · Acta Neuropathologica Communications
  67. Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
    Emily J. Koller, Paramita Chakrabarty · 2020 · Frontiers in Molecular Neuroscience
  68. 14‐3‐3ε marks the amyloid‐stimulated microglia long‐term activation
    Laura Di Francesco, Virginia Correani, Cinzia Fabrizi, Lorenzo Fumagalli, Michele Mazzanti, Bruno Maras, Maria Eugenia Schininà · 2011 · PROTEOMICS
  69. Future Directions in Imaging Neurodegeneration
    Joseph C. Masdeu · 2017 · Current Neurology and Neuroscience Reports
  70. Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies
    Szymon Kotarba, Marta Kozłowska, Małgorzata Scios, Kamil Saramowicz, Julia Barczuk, Zuzanna Granek, Natalia Siwecka, Wojciech Wiese, Michał Golberg, Grzegorz Galita et al. · 2024 · International Journal of Molecular Sciences
  71. The persistent impact of adolescent binge alcohol on adult brain structural, cellular, and behavioral pathology: A role for the neuroimmune system and epigenetics
    Leon G. Coleman, Fulton T. Crews, Ryan P. Vetreno · 2021 · International review of neurobiology
  72. Neurotoxicity of diesel exhaust extracts in zebrafish and its implications for neurodegenerative disease
    Sung Min Ha, Lisa M. Barnhill, Sharon Li, Jeff M. Bronstein · 2022 · Scientific Reports
  73. Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
    Isidró Ferrer · 2022 · Free Neuropathology
  74. P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes
    Paula Beltran-Lobo, Martina M. Hughes, C. Troakes, C. L. Croft, H. Rupawala, Daniel Jutzi, M. Ruepp, Maria Jimenez-Sanchez, M. Perkinton, Michael Kassiou et al. · 2023 · Brain, behavior, and immunity
  75. Insufficient Resolution Response in the Hippocampus of a Senescence-Accelerated Mouse Model — SAMP8
    Xiuzhe Wang, Elena Puerta, Ángel Cedazo-Mı́nguez, Erik Hjorth, Marianne Schultzberg · 2014 · Journal of Molecular Neuroscience
  76. Alzheimer’s Disease, Sleep Disordered Breathing, and Microglia: Puzzling out a Common Link
    Tyler Kent Ulland, Andrea C. Ewald, Andrew O. Knutson, Kaitlyn M. Marino, Stephanie M. C. Smith, Jyoti J. Watters · 2021 · Cells
  77. Systemic Inflammation Causes Microglial Dysfunction With a Vascular AD phenotype
    Praveen Bathini, Isabel Dupanloup, Elena Zenaro, Eleonora Terrabuio, Amrei Fischer, Edona Ballabani, Marie‐Agnès Doucey, Lavinia Auber Alberi · 2022 · Brain Behavior & Immunity - Health
  78. Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
    Luis Enrique Arroyo‐García, Sara Bachiller, Rocío Ruiz, Antonio Boza‐Serrano, Antonio Rodríguez Moreno, Tomas Deierborg, Yuniesky Andrade‐Talavera, André Fisahn · 2023 · Translational Neurodegeneration
  79. Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias
    Hye Joo Son, Jungsu S. Oh, Jee Hoon Roh, Sang Won Seo, Minyoung Oh, Sang Ju Lee, Seung Jun Oh, Jae Seung Kim · 2018 · European Journal of Nuclear Medicine and Molecular Imaging
  80. Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex
    Fani Koukouli, Marie Rooy, Uwe Maskos · 2016 · Aging
  81. Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA‐binding protein‐43 kDa
    Garam Kım, Kabriya Bolbolan, Tamar D. Gefen, Sandra Weıntraub, Eileen H. Bigio, Emily Joy Rogalski, Marsel M. Mesulam, Changiz Geula · 2018 · Annals of Neurology
  82. Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia
    Daniel T. Ohm, Garam Kım, Tamar D. Gefen, ALFRED W. RADEMAKER, Sandra Weıntraub, Eileen H. Bigio, Marsel M. Mesulam, Emily Joy Rogalski, Changiz Geula · 2018 · Neuropathology and Applied Neurobiology
  83. MORPHIOUS: an unsupervised machine learning workflow to detect the activation of microglia and astrocytes
    Joseph Silburt, Isabelle Aubert · 2022 · Journal of Neuroinflammation
  84. A review of autophagy mechanism of statins in the potential therapy of Alzheimer’s disease
    Lu Liu, Wen-Zhuo Dai, Xi‐Chen Zhu, Tao Ma · 2022 · Journal of Integrative Neuroscience
  85. Natural products as potential modulators of pro-inflammatory cytokines signalling in Alzheimer's disease
    Vikas Yadav, Chandrasekaran Mythri, Murali Kumarasamy · 2024 · Brain Behavior and Immunity Integrative
  86. AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy
    Antonella Borreca, Valentina Latina, Veronica Corsetti, Silvia Middei, Sonia Piccinin, Francesco Della Valle, Rossana Bussani, Martine Ammassari‐Teule, Robert Nisticò, Pietro Calissano et al. · 2018 · Molecular Neurobiology
  87. In Vivo Two Photon Imaging of Astrocytic Structure and Function in Alzheimer’s Disease
    Patricia Kelly, Eloïse Hudry, Steven S. Hou, Brian J. Bacskai · 2018 · Frontiers in Aging Neuroscience
  88. Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease
    Jerzy Węgiel, Michael J. Flory, Izabela Kuchna, Krzysztof Nowicki, Shuang Yong Ma, Jarek Wegiel, Eulalia Badmajew, Mony J. de Leon, Thomas Wısnıewskı, ‌Barry Reisberg · 2020 · Journal of Neuropathology & Experimental Neurology
  89. An immune response characterizes early Alzheimer’s disease pathology and subjective cognitive impairment in hydrocephalus biopsies
    Wenrui Huang, Anne Marie W. Bartosch, Harrison Xiao, Suvrajit Maji, Elliot H. H. Youth, Xena E. Flowers, Sandra Leskinen, Zeljko Tomljanovic, Gail M. Iodice, Deborah M. Boyett et al. · 2021 · Nature Communications
  90. Dynamic network model reveals distinct tau spreading patterns in early- and late-onset Alzheimer disease
    Wha Jin Lee, Hanna Cho, Min Seok Baek, Han‐Kyeol Kim, Jae‐Hoon Lee, Young Hoon Ryu, Chul Hyoung Lyoo, Joon‐Kyung Seong · 2022 · Alzheimer s Research & Therapy
  91. A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
    Kevin Llewelyn Batenburg, Claudia Sestito, Paulien Cornelissen‐Steijger, Jan R.T. van Weering, Leo Price, Vivi Majella Heine, Wiep Scheper · 2023 · Biological Procedures Online
  92. Investigating the Spatial Associations Between Amyloid-β Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer’s Disease
    Lília Jorge, Ricardo Martins, Nádia Canário, Ana Carolina Xavier, Antero Abrunhosa, Isabel J. Santana, Miguel S. Castelo-Branco · 2021 · Journal of Alzheimer s Disease
  93. Entering a new era of quantifying glutamate clearance in health and disease
    Kyle J. Brymer, Jocelyn R. Barnes, Matthew P. Parsons · 2021 · Journal of Neuroscience Research
  94. A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces neurogliosis in female Alzheimer’s mice
    Khaled S. Abd‐Elrahman, Tash‐Lynn L. Colson, Shaarika Sarasija, Stephen S. G. Ferguson · 2024 · Biomedicine & Pharmacotherapy
  95. Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets
    Shamseddin Ahmadi, Shiler Khaledi, Kimia Ahmadi, Kambiz Hassanzadeh · 2025 · CNS Neuroscience & Therapeutics
  96. An overview on microglial origin, distribution, and phenotype in Alzheimer's disease
    Rezwanul Islam, Hadi Hasan Choudhary, Robin G. Rajan, Frank D. Vrionis, Khalid A. Hanafy · 2022 · Journal of Cellular Physiology
  97. Association between APOE genotype and microglial cell morphology
    Courtney M. Kloske, Mary D Gearon, Erica M. Weekman, Colin B. Rogers, Ela Patel, Adam D. Bachstetter, Peter T. Nelson, Donna M. Wilcock · 2023 · Journal of Neuropathology & Experimental Neurology
  98. Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice
    Anna Mengr, Veronika Strnadová, Štěpán Strnad, Vladimír Vrkoslav, Helena Pelantová, Marek Kuzma, Thomas Comptdaer, Blanka Železná, Jaroslav Kuneš, Marie‐Christine Galas et al. · 2023 · Nutrients
  99. Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
    A. Tolédano, Arantxa Rodríguez‐Casado, María‐Isabel Álvarez, Adolfo Toledano‐Díaz · 2024 · Brain Sciences
  100. Microglia activation linking amyloid-β drive tau spatial propagation in Alzheimer's disease
    Qing Wang, Chunming Xie · 2022 · Frontiers in Neuroscience